Parameswaran Hari

Company: Iovance Biotherapeutics

Job title: SVP, Clinical Science

Seminars:

Improving the Efficacy of Adoptive T Cell Therapy by Leveraging the Polyclonality of TIL 4:15 pm

• Efficacy of polyclonal TIL: current data in solid tumors • What’s next: genetically modified TIL • Ensuring success and access to TIL therapyRead more

day: Day One